Array Biopharma’s asthma drug helps lung function in study – Denver Post

Array Biopharma's asthma drug helps lung function in study
Denver Post
Boulder-based Array Biopharma Inc. said one of its drugs met the main goal of improving lung function in a mid-stage study among patients with mild to moderate persistent allergic asthma. Array shares rose 10.4 percent Tuesday, to close at $6.14 after 
Array Seeks Asthma Drug Partner Following Mid-Stage Study ResultsTheStreet.com
Array Shares Climb After Asthma Drug Shows Positive Phase 2 ResultsXconomy
Array BioPharma: ARRY-502 Meets Primary And Secondary Endpoints In NASDAQ
FierceBiotech –The Pharma Letter
all 15 news articles »

View full post on asthma – Google News

Free Webinar Helps Physicians Better Care for Patients With Asthma — AAFP … – AAFP News Now

Free Webinar Helps Physicians Better Care for Patients With Asthma — AAFP
AAFP News Now
Family physicians, always on the hunt for better ways to manage the care of their patients with asthma, have an opportunity to learn more on the topic from two physician experts who will co-host a free webinar, The Patient Journey: Implementing

View full post on asthma – Google News

Experimental asthma drug helps untreatable patients in study – CBS News


CBS News

Experimental asthma drug helps untreatable patients in study
CBS News
Asthma suffers who aren't helped by existing medications may have reason to breathe a sigh of relief. An experimental drug called dupilumab was shown to reduce asthma attacks and helped boost lung function for people with moderate to severe asthma
New drug could reduce asthma attacks by 87 percentFox News
Experimental drug touted as potential game changer for asthma sufferersSyracuse.com (blog)
UPDATE 1-Regeneron, Sanofi asthma drug seen as potential game changerReuters
Forbes –SheKnows.com –Science Daily (press release)
all 25 news articles »

View full post on asthma – Google News